SCHEMBL648740

SCHEMBL648740

Cn1cc(N)cc1C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16271028 0.74
SCHEMBL2072144 0.74 HDAC8 (0.58)
SCHEMBL5393454 0.73
SCHEMBL22342725 0.73
SCHEMBL4848806 0.71 ATM (0.57)
SCHEMBL4037083 0.70 ATM (0.40)
SCHEMBL2072141 0.70 ATM (0.40)
SCHEMBL5400147 0.70 ATM (0.40)
SCHEMBL12582112 0.70 ATM (0.40)
SCHEMBL20458727 0.69 ATM (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9982020-B2 Antiviral compounds and methods for treating infections caused by double-stranded DNA viruses THE CURATORS OF THE UNIVERSITY OF MISSOURI 2018-05-29 US claimed
CN-104024247-B Be useful on treatment human papilloma virus's the polyamide being replaced by guanidine radicals NANOVIR LLC (US) 2016-05-25 CN claimed
US-9333232-B2 Methods for treating papilloma virus infection NANOVIR LLC (US) 2016-05-10 US claimed
US-9290551-B2 Compounds for treating papilloma virus infection NANOVIR LLC (US) 2016-03-22 US claimed
WO-2016022664-A1 ANTIVIRAL COMPOUNDS AND METHODS FOR TREATING INFECTIONS CAUSED BY DOUBLE-STRANDED DNA VIRUSES NANOVIR LLC (US) 2016-02-11 WO claimed
US-20150329596-A1 ANTIVIRAL COMPOUNDS AND METHODS FOR TREATING INFECTIONS CAUSED BY DOUBLE-STRANDED DNA VIRUSES THE CURATORS OF THE UNIVERSITY OF MISSOURI 2015-11-19 US claimed
US-9133228-B2 Guanidinyl-substituted polyamides useful for treating human papilloma virus NANOVIR LLC (US) 2015-09-15 US claimed
US-20150239943-A1 COMPOUNDS FOR TREATING PAPILLOMA VIRUS INFECTION THE CURATORS OF THE UNIVERSITY OF MISSOURI 2015-08-27 US claimed
US-8993609-B2 Compounds for treating papilloma virus infection NANOVIR, LLC (US) 2015-03-31 US claimed
CN-104024247-A GUANIDINYL-SUBSTITUTED POLYAMIDES USEFUL FOR TREATING HUMAN PAPILLOMA VIRUS NANOVIR LLC 2014-09-03 CN claimed
WO-2013055825-A2 GUANIDINYL-SUBSTITUTED POLYAMIDES USEFUL FOR TREATING HUMAN PAPILLOMA VIRUS NANOVIR, LLC (US) 2013-04-18 WO claimed
US-20130090362-A1 GUANIDINYL-SUBSTITUTED POLYAMIDES USEFUL FOR TREATING HUMAN PAPILLOMA VIRUS NANOVIR, LLC (US) 2013-04-11 US claimed
US-20120225809-A1 COMPOUNDS FOR TREATING PAPILLOMA VIRUS INFECTION NANOVIR, LLC (US) 2012-09-06 US claimed
US-8119677-B2 Polyamides containing amino butyric acid-based building blocks NANOVIR, LLC (US) 2012-02-21 US claimed
US-20100015084-A1 Compounds for Treating Papilloma Virus Infection NANOVIR, LLC (US) 2010-01-21 US claimed
US-20090306164-A1 Methods for Treating Papilloma Virus Infection NANOVIR, LLC (US) 2009-12-10 US claimed
EP-2013200-A2 POLYAMIDES FOR TREATING HUMAN PAPILLOMA VIRUS Nanovir, LLC (US) 2009-01-14 EP claimed
US-20070293417-A1 Polyamides for treating human papilloma virus NANOVIR, LLC 2007-12-20 US claimed
WO-2007130616-A2 POLYAMIDES FOR TREATING HUMAN PAPILLOMA VIRUS NANOVIR, LLC (US) 2007-11-15 WO claimed
WO-2007103584-A2 POLYAMIDES FOR TREATING HUMAN PAPILLOMA VIRUS NANOVIR, LLC (US) 2007-09-13 WO claimed